Home Tags Fleximer linker technology

Tag: Fleximer linker technology

Millennium/Takeda Exercises Commercial License Right for Fleximer Technology

Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited has exercised an option to license commercial rights for its first novel Fleximer® antibody-drug conjugate or ADC developed as part of their collaboration with Mersana Therapeutics, announced earlier this year.

ASN004 Shows Potent, Selective Antiproliferative Activity in Tumor Cell Lines

ASN004 shows strong tumor regression resulting in tumor-free animals in multiple tumor xenograft models, at well-tolerated doses.

X